In Committee from the Senate of Canada

Loading video...

In Committee from the Senate of Canada - Social Affairs, Science and Technology - March 7, 2013

Social Affairs, Science and Technology

Senators continue their discussions on off-label use of prescription pharmaceuticals. Off-label refers to the practice of prescribing medication for a use not approved of by a regulatory body.

Dr. Brian O'Rourke from the Canadian Agency for Drugs and Technologies in Health, Dr. Paula Rochon of the Institute for Clinical Evaluative Sciences and Dr. Stuart MacLeod with the Child and Family Research Institute (as an individual) outline some of the concerns and benefits of the common practice.

more less

Related Videos

Question Period

June 10, 2016

Parliamentary secretary Omar Alghabra (Foreign Affairs) faces Conservative calls for a referendum on possible electoral reforms....

Headline Politics

Ministers Discuss...

At a press conference in Ottawa on June 20, 2016, federal ministers announce a comprehensive review of Canada’s environmental regulations...

Question Period

June 9, 2016

Justice Minister Jody Wilson-Raybould and Health Minister Jane Philpott address concerns about the constitutionality of Bill C-14, the...

Question Period

June 1, 2016

In light of Canadian soldiers coming under fire during an incident in Iraq, Prime Minister Justin Trudeau is asked whether the Canadian...